Genmab 2024 Annual Report
JP Morgan 2025 Presentation
Patient Commitment
Commitment to the Environment and Sustainability
Genmab R&D Update and ASH Data Review - December 2024
General Terms and Conditions of Purchase
Interim Report for the First Nine Months of 2024
Genmab First Nine Months 2024 Financial Results Presentation
Genmab First Half 2024 Financial Results Presentation
Interim Report for the First Half of 2024
Genmab's Virtual mid- to late-stage pipeline update at ASCO 2024
Diversity, Equity and Inclusion Policy
Genmab Q1 2024 Financial Results Presentation
Interim Report for the First Quarter of 2024
Voting Results of the Annual General Meeting 2024
ProfoundBio Acquisition
Genmab 2023 Annual Report
AGM 2024 Presentation
Corporate Responsibility Report 2023
Corporate Governance Report 2023 - English
Genmab 2023 Full Year Financial Results Presentation
Compensation Report 2023
Genmab 2024 JP Morgan Presentation
Clinical Trial Transparency Declaration
Interim Report for the First Nine Months of 2023
Interim Report for the First Half of 2023
- First page
- Previous page
- Page 2 of 9
- Next page
- Last page